baber/WOPTO huggingface dataset:
Patent AU-4063799-A (AU)
Title: Hydrazinium nitroformate based high performance solid propellants
Inventor: LOUWERS JEROEN
IPC: C06D5/00
Filed: 1999-05-19
Abstract: The present invention is directed to a solid propellant for rocket motors, gas generators and comparable devices, comprising a cured composition of hydrazinium nitroformate and an unsaturated hydroxyl terminated hydrocarbon compound.
Patent AU-4101689-A (AU)
Title: Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides
Inventor: WALKER HANS DR
IPC: A61K47/00
Filed: 1989-09-01
Abstract: The invention relates to transdermally applicable pharmaceutical compositions which contain glycosides as active substances and which are characterised in that ethoxylated sterols and/or C12-C30 alcohols are employed as solubilisers in lipophilic phase.
Patent AU-4154485-A (AU)
Title: Can openers
Inventor: PORUCZNIK PAUL
IPC: B67B7/52
Filed: 1985-03-29
Abstract: In a can opener having a traction wheel (18) for driving the end seam (26) of a can past the opener, and a cutter wheel (16) for severing the outer seaming wall of the seam, the axes (36,38) of the wheels being mutually perpendicular, the working parts are carried in a common cartridge (58) of metal, mounted removably in the housing (10) of the opener, the cutter wheel and its spindle (74) being integral with each other and mounted in a separate bearing cup (66) fixed in the body (60) of the cartridge and having a thrust bearing (68) remote from the cutter wheel. The housing carries a projecting abutment (54) having a forwardly curved seam-engaging surface which enables a variety of shapes and sizes of cans to be opened.
Patent AU-4158789-A (AU)
Title: Collet intended to carry a tool, particularly a tapping tool
IPC: B23B31/02
Filed: 1989-09-20
Abstract: The collet comprises an outer body (1) provided with a cylindrical bore (2), and a sleeve (3) which can move axially inside the bore (2). The sleeve (3) comprises screws (8) for holding the cutting tool. The outer body (1) and the sleeve (3) are provided with prismatic surfaces (9, 10) connecting them kinematically in rotation, and means (5, 11, 12) limiting the axial displacement of the sleeve (3) inside the bore (2). A spring (4) arranged inside the bore (2) makes it possible to return the sleeve (3) into a predetermined rest position. This tool- holding collet permits autonomous axial compensation of the difference between the liner feed movement imposed by the machine and that which the tool has, for example a tap. <IMAGE>
Patent AU-4248693-A (AU)
Title: Non-PVC coextruded medical grade port tubing
Inventor: WOO LECON
IPC: A61L31/00
Filed: 1993-05-12
Abstract: The present invention provides an improved coextruded medical grade port tubing. The medical grade port tubing provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. To this end, the present invention provides a non-PVC coextruded medical grade port tubing including: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer; and a core layer including a blend of polyamide and ethylene vinyl acetate.
Patent AU-4301189-A (AU)
Title: New thienyloxy-alkylamine derivates, their process of production and medicaments containing these compounds
Inventor: BINDER DIETER
IPC: A61K31/38
Filed: 1989-09-12
Abstract: PCT No. PCT/AT89/00084 Sec. 371 Date May 15, 1990 Sec. 102(e) Date May 15, 1990 PCT Filed Sep. 12, 1989 PCT Pub. No. WO90/02743 PCT Pub. Date Mar. 22, 1990.Thienyloxyalkylamine derivatives of the general formula:   <IMAGE> I  wherein -O-CH2-CH2-NR2R3 is in position 4 or 5 of the thiophene ring; R1 is hydrogen, halogen, CF3, alkyl or alkoxy; R2 and R3 are the same or different and are each alkyl, cycloalkyl, alkenyl or alkynyl each having up to 8 C atoms, or NR2R3 is a 5 to 7-membered saturated heterocyclic ring optionally containing a further hetero atom which is oxygen or nitrogen optionally substituted by an alkyl group having 1 to 3 C atoms; and n is an integer of 1 to 5; as well as their acid addition salts, are suitable for treatment of heart rhythm disturbances.
Patent AU-4372400-A (AU)
Title: Spoken user interface for speech-enabled devices
Inventor: GARUDADRI HARINATH
IPC: G10L15/00
Filed: 2000-03-30
Abstract: A spoken user interface for speech-enabled devices includes a processor and a set of software instructions that are executable by the processor and stored in nonvolatile memory. A user of the speech-enabled device is prompted to enter a voice tag associated with an entry in a call history of the speech-enabled device. The call history includes lists of incoming and outgoing email messages, and incoming and outgoing telephone calls. The user is prompted to enter a voice tag after associated with a telephone number or email address in the call history after a user-selected number of telephone calls has been sent from the speech-enabled device to that telephone number, or has been sent from the telephone with that telephone number to the speech-enabled device, or after a user-selected number of email messages has been sent from the speech-enabled device to that email address, or has been sent from that email address to the speech-enabled device. The user may populate a phonebook of the speech-enabled device with email addresses by sending an email message to the speech-enabled device from a computer and including additional email addresses in the To: field and/or the CC: field of the email message.
Patent AU-4676093-A (AU)
Title: Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
Inventor: CALANDRA GARY B
IPC: A61K39/00
Filed: 1993-07-13
Abstract: Herpes Zoster, or varicella related post herpetic neuralgia is alleviated by immunizing people at risk of developing herpes zoster with varicella zoster virus (VZV) antigen.
Patent AU-4957697-A (AU)
Title: Method and apparatus for the coating of substrates for pharmaceutical use
Inventor: BROWN STEVEN ROBERT
IPC: A61K9/70
Filed: 1997-11-13
Abstract: A method of coating a pharmaceutical substrate includes the steps of applying an active coating material to a surface of the substrate to form an active coating layer and applying a cover coating material onto the active coating layer to form a cover coating layer. The active coating layer is substantially completely covered by the cover coating layer.
Patent AU-5082590-A (AU)
Title: Laser beam emitter
Inventor: DAIKUZONO NORIO
IPC: G02B6/00
Filed: 1990-02-14
Abstract: A laser beam emitter according to the present invention is used to incise animal tissues while keeping the device in contact therewith. This emitter is provided with an optical fiber which has at its tip an uncladded, or bared-core emitting section and which extends in the lengthwise direction thereof, and a holder for retaining this optical fiber, wherein at least a part of the emitting section is bent in one direction with respect to a longitudinal section thereof which extends in the axial direction of the emitting section.
Patent AU-5128896-A (AU)
Title: Connection system for releasable superstructures for trucks
Inventor: PERSSON AKE
IPC: B60P1/64
Filed: 1996-02-08
Abstract: Mounting means for releasable, interchangeable superstructures (3) for various types of vehicles and working machines, comprising co-operating means (5, 6) between the releasable superstructure (3) and the vehicle (1) including several tie means (5) which are mounted projecting downwardly from the superstructure (3) on each side thereof and which are rotatable about a shaft of rotation (12) extending in the longitudinal direction of the vehicle, and matching connection and locking means (4) which are mounted in the vehicle chassis (2) or in a prefabricated intermediate frame (7) which is mounted on the said chassis (2), and which comprises a locking pin (15) which is movable normally to the longitudinal direction of the vehicle, and in which said tie means (5) and said locking means (4) are formed with conical surfaces (14, 16) arranged to co-operate with each other, whereby a displacement of a locking pin (15) towards the vehicle chassis (2) and an introduction thereof in a locking recess (13) of a tie means (5) makes the superstructure (3) become pulled down and be pressed against the vehicle chassis (2).
Patent AU-5181596-A (AU)
Title: Automated analyte extraction apparatus and method
Inventor: GLEAVE GARY L
IPC: G01N30/00
Filed: 1996-02-29
Abstract: An apparatus for automated extraction of an analyte from a sample positioned in a sample containment cell having a fluid passageway structure for communication of an extraction fluid to and from the cavity of the cell. The apparatus includes a loading tray, an oven assembly mounted proximate the loading tray, a fluid communication assembly mounted proximate the tray, a cell manipulation assembly and a controller. The cell manipulation assembly brings an inlet conduit and an outlet conduit of the fluid communication assembly into sealed relationship with the sample containment cell and uses the conduits to pick up and move the cell to and from the cell tray and oven assembly. The fluid communication assembly further causes flow of an extraction fluid into the cell and pressurizes the cell for extraction of an analyte from the sample under elevated temperatures and pressures, which can be under supercritical conditions for supercritical fluid extraction but preferably are below supercritical conditions for solvent extraction. The apparatus and method include a solvent extraction soak, purging of the extracted fluid, flushing with a gas and rinsing so as to avoid contamination of subsequent analyte extractions.
Patent AU-5182686-A (AU)
Title: Pulsator for milking machines
IPC: A01J5/12
Filed: 1986-01-02
Abstract: A pulsator for milking machines has two diaphragms connected by a rod with each diaphragm dividing a pressure chamber into a processing space and a damping space. The damping spaces communicate through a channel that is provided with a throttle. The processing spaces are connected either to a source of vacuum or to the atmosphere. A switchover is attached to the rod and connects lines leading to the pulsation spaces of milking containers either to the atmosphere or to a source of vacuum. A main line is provided with a throttle. The throttles in the communicating channel and in the main line are detoured by bypasses provided with chokes that can be vacuum-activated through control channels. To improve the known pulsator by eliminating the sensitive hoses and timers and to allow adjustment of the duration of the stimulation phase with no need for a timer, the control channels are always in communication with one of the control chambers in a control disk, one chamber constantly communicating with the vacuum source and the other chambers subject to atmospheric pressure. The disk can be rotated by a transmission, which is driven by the rod as it travels back and forth, in such a way that the control channels are connected either to the control chamber that is subject to vacuum or to one of the control chambers that are subject to atmospheric pressure.
Patent AU-5223090-A (AU)
Title: Syringe having tamper evidence features
Inventor: SWEENEY NIALL
IPC: A61M5/50
Filed: 1990-03-26
Abstract: A syringe having tamper evidence features includes a barrel (21) having a chamber (22) for retaining fluid, an open proximal end (23), and a distal end (25) having a passageway (27) therethrough in fluid communication with the chamber (22). A needle shield (32) having a longitudinal axis (33), a distal end (34) and an open proximal end (35) slidably engages the distal end of the barrel covering the passageway. The shield (32) includes an outwardly projecting shield lug (37) having a cam surface (38). A collar (40) having an annular side wall (41), an open proximal end (43) and a distal end (44) having an aperture (45) therethrough, is adjacent to the distal end of the barrel with the needle shield projecting distally through the aperture. The aperture is sized so that the proximal end of the needle shield cannot pass therethrough. The collar includes an inwardly projecting lug (46) having a follower surface (47) for contacting the cam surface (38). The cam surface and the follower surface being configured so that rotational force applied to the needle shield around the longitudinal axis causes the cam surface to contact the follower surface to apply a force to the follower surface. Securement means (49) is provided for releasably holding the collar adjacent to the barrel. The securement means is positioned so that the force applied to the follower surface can disengage the securement means allowing the collar to move and allowing the needle shield to be removed from the barrel.
Patent AU-5271979-A (AU)
Title: Lightweight silica aggregate
Inventor: TEMPLE RALPH E
IPC: C04B28/26
Filed: 1979-11-12
Abstract: An improved process for the preparation of an expanded water-insoluble silicate aggregate is disclosed; in this process, anhydrous alkali metal silicate is hydrated, in the presence of a curing agent, and then subjected to rapid thermal expansion. The process eliminates the use of liquid silicates and the reaction is conducted in an essentially dry state. The expanded product has extremely low bulk density.
Patent AU-5432896-A (AU)
Title: Tricyclic compounds useful for inhibition of farnesyl protei n transferase
Inventor: DOLL RONALD J
IPC: C07D213/28
Filed: 1996-04-03
Abstract: Novel compounds of Formula   <IMAGE>   are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the Formula 1.0 to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
Patent AU-5433901-A (AU)
Title: Method of at least partly coating backing materials
Inventor: JAUCHEN PETER
IPC: B05C5/02
Filed: 2001-07-12
Abstract: The coating process deposits fluid or paste-form substances such as thermoplastics on a carrier material. The substance is applied by a jet (1) at least partially on the carrier material running along the jet. The jet body is bent transversely to the running direction of the carrier material by temperature difference induction.
Patent AU-5434100-A (AU)
Title: Sluice for discharging bulk material
Inventor: GUSTAVSSON LENNART
IPC: B65G53/46
Filed: 2000-05-24
Abstract: A sluice (2) for discharging bulk material, in particular fibers, from a cyclone device comprises a circumferential wall (4) in the form of a curved bendable band, which defines a generally cylindrical chamber (10) with an inlet (38) for receiving bulk material from the cyclone device and an outlet (14) for discharging bulk material substantially tangentially from the cylindrical chamber. A sluice wheel (16) is rotatable in the chamber about a vertical axis (12) extending through the center of the sluice wheel for sluicing the bulk material in batches from the inlet through the chamber to the outlet. The inlet (38) is situated centrally above the sluice wheel for supplying bulk material substantially axially to the slice wheel.
Patent AU-5550899-A (AU)
Title: Dispersion and stabilization of reactive atoms on the surface of metal oxides
Inventor: KLABUNDE KENNETH J
IPC: C01F11/02
Filed: 1999-08-12
Abstract: Particulate metal oxide compositions having reactive halogen atoms stabilized on particulate surfaces and methods for reacting the compositions with saturated and unsaturated species are provided. The preferred particulate metal oxides of the compositions are nanocrystalline MgO and CaO with average crystallite size of up to about 20 nm. The preferred reactive atoms of the compositions are atoms of chlorine. In one embodiment, chloride atoms are stabilized on the surface of nanocrystalline MgO thus forming a composition which is capable of halogenating compounds, both saturated and unsaturated, in the absence of UV light and elevated reaction temperatures.
Patent AU-5597990-A (AU)
Title: Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop
Inventor: KOGA TOSHIHIKO
IPC: A61K39/00
Filed: 1990-05-28
Abstract: A method for preparing a vaccine for dental caries comprises the step of culturing a variant which is obtained by integrating a protein antigen (PAc)-expressing gene into the chromosomal gene of a Streptococcus mutans GS-5 strain to obtain the protein antigen, the protein antigen being produced on the surface of cells of oral Streptococcus mutans or it being extracellularly produced by the microorganism and having a molecular weight ranging from about 170,000 to 220,000. Streptococcus mutans GS-5 (K-3), in which a protein antigen-expressing gene is integrated into the chromosomal gene thereof, has an ability of producing the protein antigen on the surface of the cells or extracellularly. A preventive vaccine composition for dental caries for nasal drops comprises the protein antigen thus produced by the strain: Streptcoccus mutans, the vaccine being intranasally administered. The method makes it possible to enhance the yield of PAc and to simplify processes for purifying PAc. The vaccine composition makes it possible to internally easily absorb the protein antigen, PAc, in high efficiency and it also makes it possible to effectively increase the antibody titer observed after the administration thereof.
Patent AU-5799898-A (AU)
Title: Method for improving the recovery of troponin i and t
Inventor: BUECHLER KENNETH F
IPC: G01N33/68
Filed: 1997-12-15
Abstract: A method for the diagnosis of heart muscle damage comprising: 
using an immunoassay system to determine the amount of cardiac troponin I in a blood, plasma, or serum sample supspected of containing troponin from damaged heart muscle, said system comprising (a) formation of an antibody conjugate comprising an antibody coupled to a signal generating element, said antibody being capable of specifically binding to cardiac specific regions of the troponin I complexes and of unbound troponin I, (b) formation of a reaction mixture comprising said whole blood, plasma or serum sample incubated with said antibody conjugate, (c) application of said reaction mixture to a surface to which is bound at least one capture antibody capable of specifically binding to cardiac specific regions of troponin I, said capture antibody binding said antibody conjugate, whereby the immobilized conjugate produces a detectable signal upon formation of sandwich complexes, and (d) relating of the detectable signal to the amount of cardiac troponin I present in said sample, wherein said antibody is insensitive with respect to the free troponin I and cardiac troponin I complexed with troponin C and troponin T, i.e. yields an assay response for said free and complexed forms of cardiac troponin I that is the same within a factor of 2; and 
relating the amount of cardiac troponin I present in said sample to the occurrence or non-occurrence of heart muscle damage.
Patent AU-5893401-A (AU)
Title: Tilting vehicle provided with steerable rear wheels
Inventor: BRINK CHRISTOPHER RALPH VAN DE
IPC: B62K5/027
Filed: 2001-05-18
Abstract: A tilting vehicle with a front frame section has a longitudinal axis, a driver's seat and one or more wheels that are able to turn about a front wheel steering axis located transversely to the longitudinal axis. The vehicle has a rear frame section with two wheels that is connected to the front frame section such that it can tilt. The vehicle can have a tilting device operated by the driver, for relative tilting of the front and rear frame sections. A sensor measures a force or movement on the front wheel for controlling the tilting device. The rear wheels can be turned about a rear wheel steering axis located transversely to the longitudinal axis or can be tilted about a rear wheel tilt axis located essentially in the direction of the longitudinal axis in order to prevent oscillations of the vehicle at relatively high speeds.
Patent AU-6235800-A (AU)
Title: Therapeutic compounds comprised of anti-fc receptor binding agents
Inventor: DEO YASHWANT M
IPC: C07K19/00
Filed: 2000-07-25
Abstract: Multispecific molecules which induce effector cell-mediated killing of target cells are disclosed. The molecules are "multispecific" because they bind to multiple (two or more), distinct targets, one of which is an Fc receptor on the surface of an immune cell. Multispecific molecules of the invention include molecules comprised of at least one portion which binds to an Fc receptor, such as an Fc gamma  receptor (e.g., Fc gamma RI) or an Fc alpha  receptor, and at least one other portion which binds to a different target, such as an antigen on a tumor cell or a pathogen. Multispecific molecules of the invention also include antigen "multimer complexes" comprised of multiple (i.e., two or more) portions which bind to a molecule on an antigen presenting cell (APC), such as an Fc receptor, linked to one or more antigens. These multimer complexes target antigens, such as self-antigens, to APCs to induce and/or enhance internalization (endocytosis), processing and/or presentation of the antigen by the APC. Therefore, these molecules can be used to induce or enhance an immune response either <i>in vivo</i> or <i>in vitro</i> against a normally non-immunogenic protein, such as a self-antigen. In a particular embodiment, at least one portion of the multispecific molecules comprises a humanized or human antibody or antibody fragment (e.g., ScFv or Fab') which binds to an Fc receptor or a receptor on a target cell (e.g., EGF-R or HER2).
Patent AU-6247994-A (AU)
Title: Condensed-phase microparticle composition and method
Inventor: FERNANDEZ JULIO M
IPC: A61K9/16
Filed: 1994-02-10
Abstract: An encapsulated microparticle composition and its method of use in drug delivery and diagnostic applications are disclosed. Also disclosed are methods of storing and administering drug compounds at high concentration in condensed-phase microparticles.
Patent AU-6252686-A (AU)
Title: Azolyl-derivatives endowed with antifungal activity
Inventor: COLLE ROBERTO
IPC: A01N43/653
Filed: 1986-09-09
Abstract: Disclosed are compounds, having the general formula: wherein:m = 0, 1, 2; n = 0, 1 with the condition that when m = 0, also n = 0;p = 0, 1; q = 1, 2;X is either oxygen or sulphur;A = N, CH;R is H, CH₃, F;R₁ is selected from chlorine, bromine, fluorine, CF₃, phe­nyl, C₁-C₂-alkoxy, C₁-C₂-haloalkoxy, alkylthio, haloalkyl­thio, wherein the halogen is Cl, Br, F;R₂ is selected from H, chlorine, bromine, fluorine;R<sub>f</sub> is selected from the group formed by alkyls containing from 2 to 4 carbon atoms, and containing at least 4 atoms of halogen selected from F, Cl and Br, of which at least 3 are F atoms; alkenyls and alkynyls containing up to 4 carbon atoms, containing at least 2 F atoms and, optionally, other halogens selected between Cl and Br.
Patent AU-6259796-A (AU)
Title: Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
Inventor: JONA JANAN
IPC: A61M37/00
Filed: 1996-06-06
Abstract: Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.